Bitcoin

Bitcoin
Bitcoin

BTC sinks below $70K, XRP plunges 14%: why the crypto market is crashing

Bitcoin fell below the $70,000 mark on Thursday, reaching its lowest level in about 15 months, as a broad risk-off sentiment swept across global financial markets and intensified pressure on digital assets. The world’s largest cryptocurrency slid as low as $69,821 in early New York trading before stabilising slightly, hovering near levels last seen around

Read More
Bitcoin

XRP holds the $1.5 support despite low retail interest: check forecast

Ripple’s XRP has been one of the worst performers among the top 10 cryptocurrencies by market cap in recent weeks.  The coin is down by less than 1% in the last 24 hours and is currently trading around $1.6 per coin. XRP is attempting to recover from last week’s sharp decline that tested support at

Read More
Bitcoin

France widens criminal probe into Elon Musk’s X after Paris office raid

French authorities have stepped up scrutiny of Elon Musk’s social media platform X after police raided its Paris offices and prosecutors broadened a long-running criminal investigation. What began as a probe into alleged algorithm abuse and data practices has now expanded to include complaints linked to the platform’s artificial intelligence chatbot, Grok, as well as

Read More
Bitcoin

Can the India-US trade breakthrough bring FIIs back to Indian equities

Indian markets have cheered the end of the impasse over the US–India bilateral trade agreement, with some analysts hoping that the breakthrough could encourage foreign investors to return to Indian equities. For much of the past year, foreign institutional investors (FIIs) have remained on the sidelines, weighed down by geopolitical uncertainty, trade frictions, and slowing

Read More
Bitcoin

Merck tops Q4 earnings expectations but issues weaker 2026 outlook

Merck closed the fourth quarter with earnings and revenue ahead of Wall Street estimates, supported by strong demand for its blockbuster cancer drug Keytruda and accelerating sales from newer medicines. The performance, however, was tempered by guidance for 2026 that landed below expectations, reflecting the growing impact of patent expirations and pricing pressures. As several

Read More
Bitcoin

ZIL rallies 71% ahead of Cancun EVM upgrade: can it go higher?

Zilliqa (ZIL) is one of the best performers among the top 200 cryptocurrencies by market cap after adding 71% to its value in the last 24 hours.  The rally comes ahead of its upcoming Cancun upgrade this week, with investors optimistic about ZIL despite the broader weakness in the crypto market.  The strong buying interest

Read More
Bitcoin

S&P 500, Nasdaq futures edge higher as earnings season intensifies

US futures largely gained on Tuesday ahead of the market open as investors digested a strong start to the month for US equities and prepared for a heavy slate of corporate earnings. Market sentiment was shaped by upbeat results from select technology names, volatility in commodities and crypto, and renewed focus on returns from artificial

Read More
Bitcoin

Oil prices to trade at $55–$65 range through Q1 2026 amid persistent oversupply, demand headwinds, warns Mind Money’s Igor Isaev

With Brent crude trading in the $65–$70 corridor and a 2.3 million barrels per day (bpd) global surplus pressuring prices, Igor Isaev, Doctor of Technical Sciences and Head of Analytics at Mind Money, sees no near-term catalysts for a breakout higher.  In an exclusive interview with Invezz, Isaev discusses persistent oversupply, Venezuela’s infrastructure challenges, Iran’s

Read More
Bitcoin

PayPal shares slide 15% on forecast and earnings; company announces new CEO

PayPal reported a weaker-than-expected fourth quarter and issued a subdued profit forecast for 2026, underscoring mounting pressure from slowing consumer spending and intensifying competition in digital payments. The company said it expects full-year adjusted profit to decline in the low-single digit percentage to increase slightly, far below Wall Street expectations of roughly 8% growth, according

Read More
Bitcoin

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Pfizer reported fourth-quarter results that beat expectations, offering a steadier earnings picture as the company moves further away from the Covid-driven revenue surge of recent years. While demand for its pandemic-era products continues to fade, the pharmaceutical group is refocusing its strategy around pipeline development, targeted acquisitions, and large-scale cost reductions. The latest earnings update

Read More